Sec Form 4 Filing - Wolfen Richard M. @ RxSight, Inc. - 2021-08-03

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Wolfen Richard M. 2. Issuer Name and Ticker or Trading Symbol RxSight, Inc. [ RXST] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) C/O RXSIGHT, INC., 100 COLUMBIA 3. Date of Earliest Transaction (MM/DD/YY) 08/03/2021 (Street) ALISO VIEJO, CA92656 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 08/03/2021 C 76,974 A $ 0 ( 1 ) ( 3 ) ( 5 ) ( 6 ) ( 8 ) ( 9 ) 78,170 D Common Stock 08/03/2021 C 1,489,805 A $ 0 ( 1 ) ( 3 ) ( 4 ) ( 5 ) ( 6 ) ( 7 ) ( 8 ) ( 9 ) 1,762,074 I See footnote ( 2 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exe rcisable Expiration Date Title Amount or Number of Shares Series A Preferred Stock ( 1 ) 08/03/2021 C 2,800 ( 1 ) ( 1 ) Common Stock 2,800 $ 0 ( 1 ) 0 D Series A Preferred Stock ( 1 ) 08/03/2021 C 11,714 ( 1 ) ( 1 ) Common Stock 11,714 $ 0 ( 1 ) 0 I See footnote ( 2 ) Series B Preferred Stock ( 3 ) 08/03/2021 C 2,017 ( 3 ) ( 3 ) Common Stock 2,017 $ 0 ( 3 ) 0 D Series B Preferred Stock ( 3 ) 08/03/2021 C 246,054 ( 3 ) ( 3 ) Common Stock 246,054 $ 0 ( 3 ) 0 I See footnote ( 2 ) Series C Preferred Stock ( 4 ) 08/03/2021 C 398,810 ( 4 ) ( 4 ) Common Stock 408,814 $ 0 ( 4 ) 0 I See footnote ( 2 ) Series D Preferred Stock ( 5 ) 08/03/2021 C 10,807 ( 11 ) ( 5 ) ( 5 ) Common Stock 12,586 $ 0 ( 5 ) 0 D Series D Preferred Stock ( 5 ) 08/03/2021 C 43,547 ( 11 ) ( 5 ) ( 5 ) Common Stock 50,711 $ 0 ( 5 ) 0 I See footnote ( 2 ) Series E Preferred Stock ( 6 ) 08/03/2021 C 4,840 ( 6 ) ( 6 ) Common Stock 5,887 $ 0 ( 6 ) 0 D Series E Preferred Stock ( 6 ) 08/03/2021 C 18,150 ( 6 ) ( 6 ) Common Stock 22,077 $ 0 ( 6 ) 0 I See footnote ( 2 ) Series F Preferred Stock ( 7 ) 08/03/2021 C 154,886 ( 7 ) ( 7 ) Common Stock 235,499 $ 0 ( 7 ) 0 I See footnote ( 2 ) Series G Preferred Stock ( 8 ) 08/03/2021 C 42,552 ( 8 ) ( 8 ) Common Stock 42,552 $ 0 ( 8 ) 0 D Series G Preferred Stock ( 8 ) 08/03/2021 C 357,227 ( 8 ) ( 8 ) Common Stock 357,227 $ 0 ( 8 ) 0 I See footnote ( 2 ) Series H Preferred Stock ( 9 ) 08/03/2021 C 9,680 ( 9 ) ( 9 ) Common Stock 9,680 $ 0 ( 9 ) 0 D Series H Preferred Stock ( 9 ) 08/03/2021 C 157,709 ( 9 ) ( 9 ) Common Stock 157,709 $ 0 ( 9 ) 0 I See footnote ( 2 ) Warrant (right to buy) $ 12.4 08/03/2021 M( 10 ) 1,452 02/24/2017 ( 10 ) Series H Preferred Stock ( 9 ) 1,452 $ 0 ( 9 ) 0 D Series H Preferred Stock $ 12.4 08/03/2021 M( 10 ) 1,452 ( 9 ) ( 9 ) Common Stock 1,452 $ 0 ( 9 ) 1,452 D Series H Preferred Stock ( 9 ) 08/03/2021 C( 10 ) 1,452 ( 9 ) ( 9 ) Common Stock 1,452 $ 0 ( 9 ) 0 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Wolfen Richard M. C/O RXSIGHT, INC. 100 COLUMBIA ALISO VIEJO, CA92656 X Signatures /s/ Shelley Thunen, as Attorney-in-Fact 08/05/2021 Signature of Reporting Person Date

Explanation of Responses:

( 1 )All shares of the Series A Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. ( 2 )Shares held by various trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive over all such shares. ( 3 )All shares of the Series B Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. ( 4 )All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. ( 5 )All shares of the Series D Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.1647 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. ( 6 )All shares of the Series E Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.2164 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. ( 7 )All shares of the Series F Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.5205 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. ( 8 )All shares of the Series G Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. ( 9 )All shares of the Series H Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. ( 10 )The warrant was exercised for Series H Preferred Stock immediately prior to the closing of the Issuer's initial public offering of its Common Stock. ( 11 )The number of shares of Series D Preferred Stock reported as beneficially held by the Reporting Person in the Form 3 filed July 29, 2021 incorrectly allocated the number of shares directly and indirectly held.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.